Skip to content
HowShorted

LENZ Therapeutics, Inc. short interest in 2022

In 2022, LENZ Therapeutics, Inc.'s disclosed short interest ran from 5.05% of shares outstanding on 14 Jan 2022 to 1.61% on 30 Dec 2022, a change of -3.44 percentage points. The year's high was 6.95% on 31 Mar 2022 and its low 1.61% on 30 Dec 2022, averaging 3.64% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.42 days on 15 Mar 2022. Full history: LENZ Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for LENZ Therapeutics, Inc. in 2022

2022 in figures

Start of year
5.05% (14 Jan 2022)
End of year
1.61% (30 Dec 2022)
Change
-3.44 pp
High
6.95% (31 Mar 2022)
Low
1.61% (30 Dec 2022)
Average
3.64%
Highest days to cover
25.42 (15 Mar 2022)
SEC filings marked
9

Every report in 2022

LENZ Therapeutics, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20225.05%15.52
31 Jan 20224.71%8.38
15 Feb 20224.77%21.89
28 Feb 20224.94%15.84
15 Mar 20225.23%25.42
31 Mar 20226.95%5.9210-K filed, results (8-K)
14 Apr 20224.45%6.43
29 Apr 20224.21%5.47
13 May 20224.55%2.3410-Q filed, results (8-K)
31 May 20224.44%4.47results (8-K)
15 Jun 20225.33%5.34
30 Jun 20224.25%2.35
15 Jul 20224.04%4.66
29 Jul 20222.97%7.22
15 Aug 20222.62%5.3910-Q filed, results (8-K)
31 Aug 20222.64%6.90
15 Sep 20222.42%6.41
30 Sep 20222.27%7.37
14 Oct 20222.23%15.85
31 Oct 20222.15%7.05
15 Nov 20222.02%3.1110-Q filed, results (8-K)
30 Nov 20221.81%7.35
15 Dec 20221.75%15.68
30 Dec 20221.61%6.44

See also: LENZ Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.